Bausch + Lomb appoints Karen Ling to its Board of Directors

– CANADA, ON –  Bausch + Lomb Corporation (TSX: BLCO / NYSE: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the appointment of Karen Ling to its Board of Directors, effective immediately.

“With her extensive industry leadership experience and time as a public company director, Karen brings significant human capital management, corporate governance and shareholder engagement expertise to the organization. We’re confident her perspectives will be highly additive in the boardroom as Bausch + Lomb continues its evolution,” said Chairman and CEO, Brent Saunders.

The company also announced that Richard De Schutter will retire from the Board at the 2024 AGM.

About Karen L. Ling

Karen Ling is the former EVP and CHRO at American International Group, Inc. and, before that, at Allergan. She previously held senior human resources roles at Merck and Wyeth. Karen Ling is currently a director – and chair of the Compensation and Human Capital Management Committee – of iRythym Technologies and has served on the Boards of Mallinckrodt Plc and TherapeuticsMD Inc. She also serves as a member of the Advisory Committee of Galderma. Additionally, Karen Ling is a member of the board of two nonprofits: ExpandEd Schools and the JED Foundation.

Karen Ling said, “I have long admired Bausch + Lomb’s reputation in eye health, and am excited to join such a dynamic and innovative organization as it executes an ambitious global growth strategy. I look forward to helping the company deliver value for all stakeholders in 2024 and beyond.”

She holds a B.A. in Economics from Yale University and a J.D. from the Boston University School of Law.

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products, and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing, and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey.


- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.